Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene Hugo description Value Type Network Comparison Type Filtered Interaction Map red green network_comparison
Results: HTML CSV LaTeX Showing element 375 to 424 of 502 in total 
Value Type: Ranked
Network Comparison Type: Divided
Filtered: 0
Interaction Map: High confidence

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
375\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TAF9B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
tbp-associated factor 9l; neuronal cell death-related protein; taf9-like rna polymerase ii, tata box binding protein (tbp)-associated factor, 31 kd; neuronal cell death-related gene in neuron-7; transcription associated factor tafii31l; transcription initiation factor iid, 31kd subunit. [source:refseq;acc:nm\_015975]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
14247.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
13686.9\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04097\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
376\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
UQCRC1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ubiquinol-cytochrome c reductase complex core protein i, mitochondrial precursor (ec 1.10.2.2). [source:swissprot;acc:p31930]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10284.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10695.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03993\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
377\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ITGB3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
integrin beta-3 precursor (platelet membrane glycoprotein iiia) (gpiiia) (cd61 antigen). [source:swissprot;acc:p05106]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
14512.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
13958.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0397\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
378\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DCHS1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
protocadherin 16 precursor (cadherin 19) (cadherin fibroblast 1). [source:swissprot;acc:q96jq0]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
19713.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
18962.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0396\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
379\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PSMD10\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
26s proteasome non-atpase regulatory subunit 10 (26s proteasome regulatory subunit p28) (gankyrin). [source:swissprot;acc:o75832]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11228.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10806\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03909\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
380\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
40s ribosomal protein s27 (metallopan-stimulin 1) (mps-1). [source:swissprot;acc:p42677]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9566.15\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9936.37\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0387\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
381\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RPS27L\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ribosomal protein s27-like protein; 40s ribosomal protein s27 isoform. [source:refseq;acc:nm\_015920]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9565.54\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9935.19\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03864\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
382\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ACTG1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
actin, cytoplasmic 2 (gamma-actin). [source:swissprot;acc:p02571]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10449\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10061.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03848\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
383\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CDYL2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
chromodomain y-like protein 2. [source:refseq;acc:nm\_152342]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10273.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10665.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03816\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
384\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
BYSL\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
bystin. [source:swissprot;acc:q13895]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10833.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
11244.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03796\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
385\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CDY2B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
testis-specific chromodomain protein y protein 2. [source:swissprot;acc:q9y6f7]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10302.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10686.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03727\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
386\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CDY1B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
testis-specific chromodomain y protein 1. [source:swissprot;acc:q9y6f8]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10303.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10687.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03724\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
387\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DTYMK\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
thymidylate kinase (ec 2.7.4.9) (dtmp kinase). [source:swissprot;acc:p23919]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10481.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10869.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03699\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
388\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
peroxisomal 3,2-trans-enoyl-coa isomerase (ec 5.3.3.8) (dodecenoyl-coa delta-isomerase) (d3,d2-enoyl-coa isomerase) (dbi-related protein 1) (drs-1) (hepatocellular carcinoma-associated antigen 88). [source:swissprot;acc:o75521]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9953.39\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10320.9\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03692\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
389\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HOMER1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
homer, neuronal immediate early gene, 1b. [source:refseq;acc:nm\_004272]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11794.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
11375.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03686\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
390\vspace{3pt}}&\multirow{12}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
alpha-nac protein. [source:sptrembl;acc:q9h009]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
14204.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
14724.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03662\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
391\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
nascent-polypeptide-associated complex alpha polypeptide. [source:refseq;acc:nm\_005594]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
14223.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
14738.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03618\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
392\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
seven in absentia homolog 1. [source:refseq;acc:nm\_003031]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9854.67\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10201.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03518\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
393\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
transcription elongation factor a protein 1 (transcription elongation factor s-ii protein 1) (transcription elongation factor tfiis.o). [source:swissprot;acc:p23193]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12576\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
13010\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03451\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
394\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
60s ribosomal protein l12. [source:swissprot;acc:p30050]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10196.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9857.79\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0344\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
395\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
dj999l4.1 (novel protein similar to ribosomal protein l12 (rpl12)). [source:sptrembl;acc:q9nq02]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10195.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9856.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03437\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
396\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
60s ribosomal protein l12 like protein. [source:sptrembl;acc:o60886]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10194.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9856.12\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03436\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
397\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
60s ribosomal protein l10a (csa-19). [source:swissprot;acc:p53025]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10006.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9676.53\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03414\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
398\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
glycerol kinase (ec 2.7.1.30) (atp:glycerol 3-phosphotransferase) (glycerokinase) (gk). [source:swissprot;acc:p32189]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
16699.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
17267.9\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03406\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
399\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
glycerol kinase, testis specific 1 (ec 2.7.1.30) (atp:glycerol 3- phosphotransferase) (glycerokinase) (gk). [source:swissprot;acc:q14409]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
16703.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
17271.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03402\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
400\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
glycerol kinase, testis specific 2 (ec 2.7.1.30) (atp:glycerol 3- phosphotransferase) (glycerokinase) (gk). [source:swissprot;acc:q14410]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
16711\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
17278.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03395\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
401\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
transcription factor dp-1 (e2f dimerization partner 1) (drtf1- polypeptide-1) (drtf1). [source:swissprot;acc:q14186]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12305.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
11904.9\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03368\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
402\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
AP1M2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
adaptor-related protein complex 1, mu 2 subunit (mu-adaptin 2) (adaptor protein complex ap-1 mu-2 subunit) (golgi adaptor ha1/ap1 adaptin mu-2 subunit) (clathrin assembly protein assembly protein complex 1 medium chain 2) (ap-mu chain family member mu1b). [source:swissprot;acc:q9y6q5]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10562.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10918\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03367\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
403\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
udp-glucuronosyltransferase 2b17 precursor, microsomal (ec 2.4.1.17) (udpgt) (c19-steroid specific udp-glucuronosyltransferase). [source:swissprot;acc:o75795]\vspace{3pt}}&\multirow{6}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
9783.63\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
10111.2\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.03348\vspace{3pt}}}\\\cline{1-1}\cline{3-3}
\parbox{\wcA}{\vspace{3pt}\noindent
404\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
udp-glucuronosyltransferase 2b11 precursor, microsomal (ec 2.4.1.17) (udpgt). [source:swissprot;acc:o75310]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
405\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
UGT2B4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
udp-glucuronosyltransferase 2b4 precursor, microsomal (ec 2.4.1.17) (udpgt) (hyodeoxycholic acid) (hlug25) (udpgth-1). [source:swissprot;acc:p06133]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
406\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ENPEP\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
glutamyl aminopeptidase (ec 3.4.11.7) (eap) (aminopeptidase a) (apa) (differentiation antigen gp160). [source:swissprot;acc:q07075]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
407\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
UGT2B10\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
udp-glucuronosyltransferase 2b10 precursor, microsomal (ec 2.4.1.17) (udpgt). [source:swissprot;acc:p36537]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
408\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
udp-glucuronosyltransferase 2b15 precursor, microsomal (ec 2.4.1.17) (udpgt) (udpgth-3) (hlug4). [source:swissprot;acc:p54855]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
409\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DIP2B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
similar to cg7020 gene product (fragment). [source:sptrembl;acc:q96ib4]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10598.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10945.3\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03272\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
410\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
histone h4. [source:swissprot;acc:p02304]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9611.37\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9308.99\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03248\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
411\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
60s ribosomal protein l22 (epstein-barr virus small rna associated protein) (eber associated protein) (eap) (heparin binding protein hbp15). [source:swissprot;acc:p35268]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12115.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
12508.3\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0324\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
412\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ALAS1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5-aminolevulinic acid synthase, nonspecific, mitochondrial precursor (ec 2.3.1.37) (delta-aminolevulinate synthase) (delta-ala synthetase) (alas-h). [source:swissprot;acc:p13196]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8546.06\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8279.69\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03217\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
413\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PTRH2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
protein cgi-147. [source:swissprot;acc:q9y3e5]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5135.25\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5298.12\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03172\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
414\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
germ cell-less. [source:refseq;acc:nm\_022471]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10978.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10644.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03142\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
415\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
transcription factor mafg (v-maf musculoaponeurotic fibrosarcoma oncogene homolog g) (hmaf). [source:swissprot;acc:o15525]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
13571.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
13166.3\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03075\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
416\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
transcription factor mafk (erythroid transcription factor nf-e2 p18 subunit). [source:swissprot;acc:o60675]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
13607.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
13202\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03072\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
417\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LSAMP\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
limbic system-associated membrane protein precursor (lsamp). [source:swissprot;acc:q13449]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10854.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10537.9\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03007\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
418\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
blood group rh(ce) polypeptide (rhesus c/e antigens) (rh30a) (rhixb) (rh polypeptide 1) (rhpi). [source:swissprot;acc:p18577]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
16680.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
17180.3\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02995\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
419\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RHD\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
blood group rh(d) polypeptide (rhesus d antigen) (rhxiii) (rh polypeptide 2) (rhpii). [source:swissprot;acc:q02161]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
16684\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
17183\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.02991\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
420\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
blood group rh(ce) polypeptide (rhesus c/e antigens) (rh30a) (rhixb) (rh polypeptide 1) (rhpi). [source:swissprot;acc:p18577]\vspace{3pt}}&&&\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
421\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
alpha-1-acid glycoprotein 2 precursor (agp 2) (orosomucoid 2) (omd 2). [source:swissprot;acc:p19652]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11186\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10866.3\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02942\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
422\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GLUL\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
glutamine synthetase (ec 6.3.1.2) (glutamate--ammonia ligase). [source:swissprot;acc:p15104]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12581.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
12224.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02925\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
423\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CYLD\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cylindromatosis (turban tumor syndrome); cylindromatosis 1, turban tumor syndrome. [source:refseq;acc:nm\_015247]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5905\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6073\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02845\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
424\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DPP6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
dipeptidyl aminopeptidase-like protein 6 (dipeptidylpeptidase vi) (dipeptidylpeptidase 6) (dipeptidyl peptidase iv like protein) (dipeptidyl aminopeptidase-related protein) (dppx). [source:swissprot;acc:p42658]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9562.48\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9298.93\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02834\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the HGNC identifier if it exists

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/